Comparison of radiotherapy versus surgical resection following neoadjuvant chemoimmunotherapy in potentially resectable stage III non-small-cell lung cancer: A propensity score matching analysis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Comparison of radiotherapy versus surgical resection following neoadjuvant chemoimmunotherapy in potentially resectable stage III non-small-cell lung cancer: A propensity score matching analysis

Published:2024-08 Issue: Volume:194 Page:107884
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Li Rongzhen,Xu Yan,Zhao Jing,Zhang Li,Zhong Wei,Gao Xiaoxing,Liu Xiaoyan,Chen Minjiang,Wang Mengzhao

Publisher

Elsevier BV

Reference42 articles.

1. R.L. Siegel, K.D. Miller, N.S. Wagle, A. Jemal, Cancer statistics, 2023, CA: A Cancer Journal for Clinicians 73 (2023) 17–48. https://doi.org/10.3322/caac.21763.

2. The biology and management of non-small cell lung cancer;Herbst;Nature,2018

3. Perioperative pembrolizumab for early-stage non-small-cell lung cancer;Wakelee;N. Engl. J. Med.,2023

4. Neoadjuvant nivolumab plus chemotherapy in resectable lung cancer;Forde;N. Engl. J. Med.,2022

5. National Comprehensive Cancer Network, Guidelines for treatment of cancer by type: non-small cell lung cancer, 2.2024, 2024.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP